Plain-English translation of NCT06518473 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether people with chronic obstructive pulmonary disease (COPD) who have allergic tendencies — like asthma or high allergy markers in their blood — experience more frequent flare-ups of their lung symptoms. The study will help doctors understand if allergies play a role in how severe COPD becomes and whether people with both conditions need different treatment approaches.
Some people with COPD also have allergy-related symptoms similar to asthma, which may affect how often their symptoms get worse. This research aims to figure out whether treating or managing allergies could help reduce how many flare-ups these patients experience.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be evaluated to see if you have allergy markers in your blood and whether your symptoms get worse more often. This may include blood tests, breathing tests, and possibly allergy testing. The study involves about 50 participants total, and you would be monitored to track how frequently your COPD symptoms flare up.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Egypt
Enrollment target
~50 participants
Started
July 2024
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years – 70 Years
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mohamed AbdElmoniem, lecturer
Lecturer of chest medicine Faculty of medicine Mansoura university
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.